FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC
| Autor: | Slart, R. H. J. A., Glaudemans, A. W. J. M., Chareonthaitawee, P., Treglia, G., Besson, F. L., Bley, T. A., Blockmans, D., Boellaard, R., Bucerius, J., Carril, J. M., Chen, W., Cid, M. C., Dagupta, B., Dorbala, S., Gheysens, O., Hyafil, F., Jain, S., Klink, T., van der Laken, C. J., Lomena, F., Massollo, M., Prieto-Gonzalez, S., Luqmani, R., Roivainen, A., Salvarani, C., Saraste, A., Schirmer, M., Verberne, H. J., Versari, A., Voskuyl, A. E., Walter, M. A., Camellino, D., Brouwer, E., Cimmino, M. A., Abidov, A., Agostini, D., Beanlands, R. S., Delgado-Bolton, R. C., Einstein, A. J., Gimelli, A., Miller, E. J., Sciagra, R., Signore, A. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
musculoskeletal diseases
medicine.medical_specialty Giant Cell Arteritis Disease Review Article DISEASE-ACTIVITY 030218 nuclear medicine & medical imaging Polymyalgia rheumatica 03 medical and health sciences POSITRON-EMISSION-TOMOGRAPHY 0302 clinical medicine GIANT-CELL ARTERITIS Fluorodeoxyglucose F18 Large vessel vasculitis Positron Emission Tomography Computed Tomography Imaging procedure Medicine Humans Radiology Nuclear Medicine and imaging 030203 arthritis & rheumatology FDG-PET/CT(A) medicine.diagnostic_test business.industry ABATACEPT CTLA-4IG SEMIQUANTITATIVE ANALYSIS TAKAYASU ARTERITIS EARLY-DIAGNOSIS General Medicine medicine.disease DOUBLE-BLIND TRIAL Functional imaging Giant cell arteritis Positron emission tomography Polymyalgia Rheumatica Positron-Emission Tomography Public Opinion Interest group Angiography F-18 FDG-PET/CT Radiology FOLLOW-UP business |
| Zdroj: | European Journal of Nuclear Medicine and Molecular Imaging Slart, R H J A, Glaudemans, A W J M, Chareonthaitawee, P, Treglia, G, Besson, F L, Bley, T A, Blockmans, D, Boellaard, R, Bucerius, J, Carril, J M, Chen, W, Cid, M C, Dagupta, B, Dorbala, S, Gheysens, O, Hyafil, F, Jain, S, Klink, T, van der Laken, C J, Lomeña, F, Massollo, M, Prieto-González, S, Luqmani, R, Roivainen, A, Salvarani, C, Saraste, A, Schirmer, M, Verberne, H J, Versari, A, Voskuyl, A E, Walter, M A, Camellino, D, Brouwer, E, Cimmino, M A, Abidov, A, Agostini, D, Beanlands, R S, Delgado-Bolton, R C, Einstein, A J, Gimelli, A, Miller, E J, Sciagrà, R, Signore, A, Writing group, Reviewer group, Members of EANM Cardiovascular, Members of EANM Infection & Inflammation, Members of Committees, SNMMI Cardiovascular, Members of Council, PET Interest Group, Members of ASNC & EANM Committee Coordinator 2018, ' FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica : joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 7, pp. 1250-1269 . https://doi.org/10.1007/s00259-018-3973-8 |
| DOI: | 10.1007/s00259-018-3973-8 |
| Popis: | Large vessel vasculitis (LVV) is defined as a disease mainly affecting the large arteries, with two major variants, Takayasu arteritis (TA) and giant cell arteritis (GCA). GCA often coexists with polymyalgia rheumatica (PMR) in the same patient, since both belong to the same disease spectrum. FDG-PET/CT is a functional imaging technique which is an established tool in oncology, and has also demonstrated a role in the field of inflammatory diseases. Functional FDG-PET combined with anatomical CT angiography, FDG-PET/CT(A), may be of synergistic value for optimal diagnosis, monitoring of disease activity, and evaluating damage progression in LVV. There are currently no guidelines regarding PET imaging acquisition for LVV and PMR, even though standardization is of the utmost importance in order to facilitate clinical studies and for daily clinical practice. This work constitutes a joint procedural recommendation on FDG-PET/CT(A) imaging in large vessel vasculitis (LVV) and PMR from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine (EANM), the Cardiovascular Council of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), and the PET Interest Group (PIG), and endorsed by the American Society of Nuclear Cardiology (ASNC). The aim of this joint paper is to provide recommendations and statements, based on the available evidence in the literature and consensus of experts in the field, for patient preparation, and FDG-PET/CT(A) acquisition and interpretation for the diagnosis and follow-up of patients with suspected or diagnosed LVV and/or PMR. This position paper aims to set an internationally accepted standard for FDG-PET/CT(A) imaging and reporting of LVV and PMR. Electronic supplementary material The online version of this article (10.1007/s00259-018-3973-8) contains supplementary material, which is available to authorized users. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|